Hanxing Technology Receives Joint Investment from Zheshang Capital and EasyDiagnosis | Multidimensional Trading
In December 2025, Nanjing Hanxing Information Technology Co., Ltd. (hereinafter referred to as "Hanxing Technology") completed its Series B+ financing. This round of financing was jointly invested by Zheshang Capital and Yirui Biotech, with Duowei Capital serving as the long - term exclusive financing advisor.
Hanxing Technology originates from data and serves the real economy. It focuses on the positioning of "store partners" and is committed to reducing costs and increasing efficiency for pet store users through supply - chain services, value - added services, and customized products. Hanxing Technology has successfully built a digital product - selection, circulation, and operation system, and established a multi - level product distribution channel that combines direct sales and distribution, as well as online and offline channels. Its channel business brands include the direct - sales channel "Veterinarians' First Choice", the distribution channel "Pet Merchants' First Choice", and the overseas channel "PETFECT". Among them, "Veterinarians' First Choice" has become the largest independent digital supply - chain service brand in the industry. The company currently has more than 20,000 SKUs, which can meet the full - category needs of stores for daily operations, including drugs, equipment, instruments, consumables, health products, food, and supplies.
The company's self - owned brand BestBene focuses on the needs of stores to reduce costs and increase efficiency. It strictly manages the product cost and price system to ensure store profitability, and has built two product series: veterinary assistance and store revenue - generation, with more than 500 carefully - developed SKUs. The concept of "only available in physical stores" of BestBene and its products have been increasingly recognized by store users. As of December 2025, BestBene products have been sold to nearly 20,000 stores across the country, and the sales volume of veterinary consumables has exceeded 40 million. Leading domestic chain hospitals and top - tier pet hospitals in Southeast Asia have all become users of BestBene.
This round of financing will be mainly used for the R & D of new BestBene products, the construction of self - owned production capacity, and the promotion of the brand in domestic and overseas markets. Hanxing Technology will deepen the construction of the joint research center for veterinary auxiliary treatment, accelerate the transformation of cutting - edge technological achievements, enhance the brand's technological barriers, and integrate the company's years of accumulated market and product data through self - built production capacity to fully realize the R & D concept of its self - owned brand and improve the user experience of its products.
Zheshang Capital is a wholly - owned subsidiary of Zheshang Securities and the first securities company's equity investment institution in Zhejiang Province. The company focuses on the construction of the "415X" advanced manufacturing cluster and the "315" scientific and technological innovation system in Zhejiang Province. It aims to contribute capital to build a modern industrial system supported by advanced manufacturing by upgrading traditional industries, cultivating and expanding emerging industries, and laying out future industries.
Yirui Biotech is a national high - tech enterprise and a national specialized and sophisticated "little giant" enterprise dedicated to fields such as food safety, animal diagnosis, and public safety. It is the first listed company in China's A - share market for rapid food - safety testing.
Hanxing Technology's joint investment from state - owned capital and listed companies this time can further integrate regional policy and industrial resources, improve industrial efficiency with digital technology, integrate upstream and downstream resources with supply - chain technology, and drive product and industrial upgrading through innovative R & D.
Previously, Hanxing Technology had received investments from well - known domestic first - tier VCs such as Xianfeng Qiyun, Xiaomi Strategic Investment, and Shunwei Capital.
END
This article is from the WeChat official account "Duowei Capital", and is published by 36Kr with authorization.